Literature DB >> 6387277

Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.

R A Scholl, C H Lang, G J Bagby.   

Abstract

Hypertriglyceridemia, commonly observed in septic patients, may result from a decreased ability of tissues to remove plasma triacylglycerol due to depressed lipoprotein lipase activity. While endotoxin administration results in substantial decreases in muscle lipoprotein lipase activity, enzyme activity is increased in animals subjected to other forms of stress and trauma. The present study was initiated to compare changes in plasma triacylglycerol concentrations and tissue lipoprotein lipase activities in rats challenged with endotoxin or live Escherichia coli (iv or ip) or rats subjected to polymicrobial peritoneal sepsis. Sixteen hours post-treatment plasma triacylglycerol levels were increased 200 to 300% in endotoxin- and E. coli-treated rats but did not differ from control animals subjected to peritoneal sepsis. At the same time, endotoxin administration resulted in significant decreases in heart (71-80%), soleus muscle (52-74%), and adipose tissue (21-32%) lipoprotein lipase activity regardless of the route injected. Intravenous E. coli also lead to a decrease in the three tissues examined while ip administration of E. coli reduced muscle and adipose tissue but not heart lipoprotein lipase activity. In contrast to endotoxemic and E. coli bacteremic rats, polymicrobial peritonitis resulted in significant increases in heart (46-89%) and skeletal muscle (18-39%) lipoprotein lipase activity. Thus, hypertriglyceridemia is not necessarily a consequence of sepsis but occurred in endotoxemic and bacteremic states when muscle and adipose tissue lipoprotein lipase activities were reduced. These findings support the postulate that sepsis-induced hypertriglyceridemia is likely to be associated with a decreased ability of lipoprotein lipase-containing tissues to clear circulating triacylglycerol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387277     DOI: 10.1016/0022-4804(84)90205-1

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

Review 1.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

2.  Effect of liposome-encapsulated hemoglobin on triglyceride, total cholesterol, low-density lipoprotein, and high-density lipoprotein cholesterol measurements.

Authors:  F Abdullah; M Whiteford; G Mathiak; P Ovadia; A Rudolph; L F Neville; R Rabinovici
Journal:  Lipids       Date:  1997-04       Impact factor: 1.880

3.  Alteration in rat apolipoprotein C-III gene expression and lipoprotein composition during inflammation.

Authors:  P Shen; G J Howlett
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

Review 4.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

5.  Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression.

Authors:  W Liao; M Rudling; B Angelin
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

6.  Is hypertriglyceridemia a prognostic factor in sepsis?

Authors:  Ali Cetinkaya; Abdulsamet Erden; Deniz Avci; Hatice Karagoz; Samet Karahan; Mustafa Basak; Kadir Bulut; Vedat Gencer; Hasan Mutlu
Journal:  Ther Clin Risk Manag       Date:  2014-02-27       Impact factor: 2.423

7.  Glucocorticoid receptor density and binding affinity in healthy horses and horses with systemic inflammatory response syndrome.

Authors:  C J Hoffman; H C McKenzie; M O Furr; A Desrochers
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

Review 8.  Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?

Authors:  Lise Van Wyngene; Jolien Vandewalle; Claude Libert
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 12.137

Review 9.  Sickness behaviour pushed too far--the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva
Journal:  Malar J       Date:  2008-10-14       Impact factor: 2.979

Review 10.  Metabolic Alterations in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.